|
Bio-Techne corporation
recombinant human vegf 121 (aa 207-327) protein, cf Recombinant Human Vegf 121 (Aa 207 327) Protein, Cf, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/recombinant human vegf 121 (aa 207-327) protein, cf/product/Bio-Techne corporation Average 94 stars, based on 1 article reviews
recombinant human vegf 121 (aa 207-327) protein, cf - by Bioz Stars,
2026-03
94/100 stars
|
Buy from Supplier |
|
PeproTech
rabbit polyclonal antisera to vegf reacting with vegf a isoforms 165 and 121 ![]() Rabbit Polyclonal Antisera To Vegf Reacting With Vegf A Isoforms 165 And 121, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/rabbit polyclonal antisera to vegf reacting with vegf a isoforms 165 and 121/product/PeproTech Average 90 stars, based on 1 article reviews
rabbit polyclonal antisera to vegf reacting with vegf a isoforms 165 and 121 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
PeproTech
isoform 121 human vegf-a ![]() Isoform 121 Human Vegf A, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/isoform 121 human vegf-a/product/PeproTech Average 90 stars, based on 1 article reviews
isoform 121 human vegf-a - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
ProSpec
vegfa121 ![]() Vegfa121, supplied by ProSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/vegfa121/product/ProSpec Average 90 stars, based on 1 article reviews
vegfa121 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
PeproTech
human vegf-a isoforms 121 and 165 ![]() Human Vegf A Isoforms 121 And 165, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human vegf-a isoforms 121 and 165/product/PeproTech Average 90 stars, based on 1 article reviews
human vegf-a isoforms 121 and 165 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
SibTech Inc
alexafluor 594-labeled vegf-a vegf-a 121-af594 ![]() Alexafluor 594 Labeled Vegf A Vegf A 121 Af594, supplied by SibTech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/alexafluor 594-labeled vegf-a vegf-a 121-af594/product/SibTech Inc Average 90 stars, based on 1 article reviews
alexafluor 594-labeled vegf-a vegf-a 121-af594 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: British Journal of Cancer
Article Title: High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT–PCR mRNA expression profile
doi: 10.1038/sj.bjc.6603796
Figure Lengend Snippet: Overview of the IHC stainings used, in low-grade (left: A, C, E, G ) and high-grade (right: B, D, F, H ) CC-RCC. ( A and B ) CD34/Ki-67 IHC double-staining. Black arrows in inset show proliferating Ki-67 positive (brown nucleus) ECs (red cytoplasm). ( C and D ) Morphometrical analyses showing an increased vessel area (grey) in high-grade CC-RCC. ( E and F ) Membranous CAIX staining and nuclear HIF-1 α staining (inset) of tumour cells. Although no significant difference was found between low- and high-grade tumours for CAIX expression, there was more HIF-1 α expression in low-grade CC-RCC. ( G and H ) Predominantly membranous VEGF staining in tumour cells of low-grade RCC ( G ), in contrast with dense cytoplasmic intratumoural VEGF staining in high-grade RCC ( H ). Insets also illustrate VEGF immunoreactivity of the intratumoural vessels.
Article Snippet: The VEGF IHC staining was performed with Rabbit polyclonal antisera to
Techniques: Double Staining Immunohistochemistry, Staining, Expressing
Journal: British Journal of Cancer
Article Title: High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT–PCR mRNA expression profile
doi: 10.1038/sj.bjc.6603796
Figure Lengend Snippet: Immunohistochemical and morphometric results of angiogenesis parameters in low-grade vs high-grade CC-RCC
Article Snippet: The VEGF IHC staining was performed with Rabbit polyclonal antisera to
Techniques: Immunohistochemical staining
Journal: eLife
Article Title: VEGFR-2 conformational switch in response to ligand binding
doi: 10.7554/eLife.13876
Figure Lengend Snippet: ( B ) CHO cells do not express VEGF endogenously. Here, CHO cells, HEK293T cells, and MECs (microvascular endothelial) cells) were stained for VEGF-A. Lysates were reduced before loading. DOI: http://dx.doi.org/10.7554/eLife.13876.005
Article Snippet: Here, a single vesicle containing YFP-tagged mutant receptors (two top rows) or wild-type receptors (bottom row) is shown after incubation with 3 μg.ml -1 AlexaFluor 594-labeled
Techniques: Staining
Journal: eLife
Article Title: VEGFR-2 conformational switch in response to ligand binding
doi: 10.7554/eLife.13876
Figure Lengend Snippet: ( A ) FRET efficiency measured as a function of acceptor concentration for EC+TM VEGFR-2, in the absence of ligand and in the presence of 3 μg.ml -1 VEGF-A 121 and VEGF-A 165 a. Two hundred to 500 individual vesicles were imaged in at least three independent experiments. Each data point corresponds to a single vesicle. The stochastic FRET contribution is shown as a solid line. Black stars: FRET data without ligand. ( B ) FRET efficiencies for individual vesicles, corrected for the stochastic FRET contribution. There is no dependence on receptor concentration, indicative of constitutive dimerization. ( C ) Donor concentrations versus acceptor concentrations. ( D ) Intrinsic FRET values, measured for VEGFR-2 EC+TM in the presence of 3 μg.ml -1 of VEGF-A 121 , VEGF-A 165 a, VEGF-A 165 b, VEGF-C, VEGF-E, and VEGF-D. ( E ) Graphical representation of the ligand-induced changes in distance between fluorescent proteins, and the inferred changes in TM domain structures. ( F ) The six VEGF ligands increase VEGFR-2 phosphorylation, to the same extent. A representative Western Blot comparing the phosphorylation of Tyr 1175 in the absence of ligand, and in the presence of six VEGF ligands, at concentrations of 3 μg.ml -1 . Only the top bands, corresponding to mature fully glycosylated receptors, are considered here. Phosphorylation is significantly increased upon ligand addition, with the increase being as high as 10 times. ( G ) Quantification of Western blot results for the fully glycosylated receptors (top bands), in the presence of the six ligands. VEGFR-2 phosphorylation in the presence of the six ligands is very similar. DOI: http://dx.doi.org/10.7554/eLife.13876.009
Article Snippet: Here, a single vesicle containing YFP-tagged mutant receptors (two top rows) or wild-type receptors (bottom row) is shown after incubation with 3 μg.ml -1 AlexaFluor 594-labeled
Techniques: Concentration Assay, Western Blot
Journal: eLife
Article Title: VEGFR-2 conformational switch in response to ligand binding
doi: 10.7554/eLife.13876
Figure Lengend Snippet: ( A ) FRET measurements for the D4 and D7 mutants, in the absence of ligand and in the presence of VEGF-A 121 . The two mutants exhibit much higher FRET efficiencies, compared to the wild-type. The ligand, at 3 μg.ml -1 , has no effect on receptor dimerization. ( B ) VEGF-A 121 does not bind to the D4→D5 mutant, when it binds to the wild-type and the D7→D6 mutant. Here, a single vesicle containing YFP-tagged mutant receptors (two top rows) or wild-type receptors (bottom row) is shown after incubation with 3 μg.ml -1 AlexaFluor 594-labeled VEGF-A (VEGF-A 121 -AF594) (SibTech Inc., CT). Note the differences in the middle column, showing the fluorescence of the bound ligand. ( C ) Western blots comparing the phosphorylation of the full-length D7→D6 mutant in the absence and presence of VEGF-A 121 . The top band corresponds to the mature fully glycosylated form of VEGFR-2. The ligand does not increase the phosphorylation. DOI: http://dx.doi.org/10.7554/eLife.13876.013
Article Snippet: Here, a single vesicle containing YFP-tagged mutant receptors (two top rows) or wild-type receptors (bottom row) is shown after incubation with 3 μg.ml -1 AlexaFluor 594-labeled
Techniques: Mutagenesis, Incubation, Labeling, Fluorescence, Western Blot
Journal: eLife
Article Title: VEGFR-2 conformational switch in response to ligand binding
doi: 10.7554/eLife.13876
Figure Lengend Snippet: ( A ) FRET efficiencies determined in individual plasma-membrane-derived vesicles. ( B ) Corrected FRET as a function of receptor concentration. The corrected FRET for the mutant does not depend on receptor concentration, demonstrating that the mutant is a constitutive dimer in the presence and absence of ligand. ( C ) Measured donor versus acceptor concentrations in each vesicle. ( D ) Histograms of measured FRET efficiencies for the mutant, yielding Intrinsic FRET values of ~0.42. ( E ) Western blots showing an increase in phosphorylation due to the C482R mutation, in the absence of ligand, and no further increase upon ligand treatment. The top bands correspond to the mature fully glycosylated form of VEGFR-2. ( F ) Confocal images of VEGF-A 121 -AF594 binding to EC+TM VEGFR-2 C482R in CHO membrane vesicles, demonstrating that the C482R mutant is capable of ligand binding. DOI: http://dx.doi.org/10.7554/eLife.13876.015
Article Snippet: Here, a single vesicle containing YFP-tagged mutant receptors (two top rows) or wild-type receptors (bottom row) is shown after incubation with 3 μg.ml -1 AlexaFluor 594-labeled
Techniques: Derivative Assay, Concentration Assay, Mutagenesis, Western Blot, Binding Assay, Ligand Binding Assay